跳至主要内容
临床试验/JPRN-jRCTs062220038
JPRN-jRCTs062220038招募中3 期

Bilateral verses bilateral with tri-segmental endoscopic drainage using metal stents for high-grade malignant hilar biliary obstructions: a multicenter, randomized controlled trial: BRAVE study - BRAVE study

Kato Hironari0 个研究点目标入组 76 人开始时间: 2022年6月23日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Unresectable malignant hilar biliary obstructions with Bismuth type IIIa or IV
  • 2. Age over 18
  • 3. Patient with fully informed consent

排除标准

  • 1. Reconstructed bowel other than Billroth 1
  • 2. Inferior border of the biliary stricture extends close to the duodenal papilla which required stenting across the papilla Vater.
  • 3. Endoscopic drainage will be ineffective due to severely divided bile duct, or severe portal vein invasion due to multiple liver metastasis. .
  • 4. Radical resection, radiation therapy, and proton/particle therapy will be planned
  • 5. Patient with pregnant or possibly pregnant.
  • 6. Patient who are not expected to live 1 month or longer
  • 7. Patient judged by the investigator to be inappropriate to enroll.

研究者

发起方
Kato Hironari

相似试验